Main Street Announces New Portfolio Investment
Main Street Capital (NYSE: MAIN) has announced a new portfolio investment of $12.5 million to facilitate the minority recapitalization of a leading vascular care management services organization in the Northeastern U.S.
The investment comprises a combination of first lien, senior secured term debt and a direct equity investment. Main Street partnered with the Company's founders for this transaction.
The healthcare company, founded in 2007, operates from two facilities in the Northeastern U.S. and specializes in vascular care, performing vein and arterial procedures. Their services focus on chronic pain alleviation, blood clot risk reduction, and restoration of blood flow in narrowed or blocked arteries. The organization emphasizes a patient-centric approach with a dedicated team of physicians and staff committed to delivering high-quality care.
Main Street Capital (NYSE: MAIN) ha annunciato un nuovo investimento di portafoglio di 12,5 milioni di dollari per facilitare la ricapitalizzazione minoritaria di un'importante organizzazione di servizi di gestione della cura vascolare nel Nord-Est degli Stati Uniti.
L'investimento comprende una combinazione di debito garantito di primo grado e un investimento diretto in capitale. Main Street ha collaborato con i fondatori dell'azienda per questa transazione.
L'azienda sanitaria, fondata nel 2007, opera da due strutture nel Nord-Est degli Stati Uniti e si specializza nella cura vascolare, eseguendo procedure venose e arteriose. I loro servizi si concentrano sull'alleviamento del dolore cronico, sulla riduzione del rischio di trombosi e sul ripristino del flusso sanguigno in arterie ristrette o bloccate. L'organizzazione enfatizza un approccio incentrato sul paziente con un team dedicato di medici e personale impegnato a fornire cure di alta qualità.
Main Street Capital (NYSE: MAIN) ha anunciado una nueva inversión en cartera de 12,5 millones de dólares para facilitar la recapitalización minoritaria de una organización líder en servicios de gestión de atención vascular en el noreste de EE. UU.
La inversión consiste en una combinación de deuda garantizada de primer grado y una inversión directa en capital. Main Street se asoció con los fundadores de la empresa para esta transacción.
La empresa de atención médica, fundada en 2007, opera desde dos instalaciones en el noreste de EE. UU. y se especializa en atención vascular, realizando procedimientos venosos y arteriales. Sus servicios se centran en el alivio del dolor crónico, la reducción del riesgo de coágulos sanguíneos y la restauración del flujo sanguíneo en arterias estrechas o bloqueadas. La organización enfatiza un enfoque centrado en el paciente con un equipo dedicado de médicos y personal comprometido a ofrecer atención de alta calidad.
Main Street Capital (NYSE: MAIN)는 미국 북동부의 선도적인 혈관 관리 서비스 조직의 소수 recapitalization을 촉진하기 위해 1250만 달러의 새로운 포트폴리오 투자를 발표했습니다.
이 투자는 첫 번째 담보 대출과 직접 주식 투자의 조합으로 구성됩니다. Main Street는 이 거래를 위해 회사의 창립자들과 협력했습니다.
2007년에 설립된 이 의료 회사는 미국 북동부의 두 개 시설에서 운영되며 혈관 치료를 전문으로 하여 정맥 및 동맥 절차를 수행합니다. 그들의 서비스는 만성 통증 완화, 혈전 위험 감소 및 좁아지거나 차단된 동맥에서의 혈류 회복에 중점을 둡니다. 이 조직은 고품질 치료를 제공하기 위해 헌신하는 의사 및 직원 팀과 함께 환자 중심의 접근 방식을 강조합니다.
Main Street Capital (NYSE: MAIN) a annoncé un nouvel investissement de portefeuille de 12,5 millions de dollars pour faciliter la recapitalisation minoritaire d'une organisation leader dans les services de gestion des soins vasculaires dans le Nord-Est des États-Unis.
L'investissement comprend une combinaison de dettes senior garanties de premier rang et d'un investissement direct en capital. Main Street a collaboré avec les fondateurs de l'entreprise pour cette transaction.
La société de santé, fondée en 2007, opère à partir de deux établissements dans le Nord-Est des États-Unis et se spécialise dans les soins vasculaires, réalisant des procédures veineuses et artérielles. Leurs services se concentrent sur le soulagement de la douleur chronique, la réduction du risque de caillots sanguins et la restauration du flux sanguin dans les artères rétrécies ou obstruées. L'organisation met l'accent sur une approche centrée sur le patient avec une équipe dédiée de médecins et de personnel engagés à fournir des soins de haute qualité.
Main Street Capital (NYSE: MAIN) hat eine neue Portfolioinvestition in Höhe von 12,5 Millionen Dollar angekündigt, um die Minderheitsrekapitalisierung einer führenden Organisation für das Management von Gefäßpflegeleistungen im Nordosten der USA zu erleichtern.
Die Investition besteht aus einer Kombination von vorrangigen, gesicherten Terminkrediten und einer direkten Eigenkapitalinvestition. Main Street hat für diese Transaktion mit den Gründern des Unternehmens zusammengearbeitet.
Das im Jahr 2007 gegründete Gesundheitsunternehmen betreibt zwei Einrichtungen im Nordosten der USA und ist auf die Gefäßpflege spezialisiert, wobei es venöse und arterielle Eingriffe durchführt. Ihre Dienstleistungen konzentrieren sich auf die Linderung chronischer Schmerzen, die Verringerung des Blutgerinnungsrisikos und die Wiederherstellung des Blutflusses in verengten oder blockierten Arterien. Die Organisation betont einen patientenorientierten Ansatz mit einem engagierten Team von Ärzten und Mitarbeitern, die sich der Bereitstellung hochwertiger Pflege verschrieben haben.
- None.
- None.
Invests
Founded in 2007 and operating out of two facilities in the
ABOUT MAIN STREET CAPITAL CORPORATION
Main Street (www.mainstcapital.com) is a principal investment firm that primarily provides customized long-term debt and equity capital solutions to lower middle market companies and debt capital to private companies owned by or in the process of being acquired by a private equity fund. Main Street's portfolio investments are typically made to support management buyouts, recapitalizations, growth financings, refinancings and acquisitions of companies that operate in diverse industry sectors. Main Street seeks to partner with entrepreneurs, business owners and management teams and generally provides customized "one-stop" debt and equity financing alternatives within its lower middle market investment strategy. Main Street seeks to partner with private equity fund sponsors and primarily invests in secured debt investments in its private loan investment strategy. Main Street's lower middle market portfolio companies generally have annual revenues between
Main Street, through its wholly owned portfolio company MSC Adviser I, LLC ("MSC Adviser"), also maintains an asset management business through which it manages investments for external parties. MSC Adviser is registered as an investment adviser under the Investment Advisers Act of 1940, as amended.
Contacts:
Main Street Capital Corporation
Dwayne L. Hyzak, CEO, dhyzak@mainstcapital.com
Ryan R. Nelson, CFO, rnelson@mainstcapital.com
713-350-6000
Dennard Lascar Investor Relations
Ken Dennard | ken@dennardlascar.com
Zach Vaughan | zvaughan@dennardlascar.com
713-529-6600
View original content:https://www.prnewswire.com/news-releases/main-street-announces-new-portfolio-investment-302416193.html
SOURCE Main Street Capital Corporation
FAQ
What is the size and structure of Main Street's (MAIN) new healthcare investment in 2025?
What type of healthcare company did Main Street (MAIN) invest in during April 2025?
How will Main Street's (MAIN) investment impact the vascular care company's ownership?
What services does Main Street's (MAIN) new healthcare portfolio company provide?
When was Main Street's (MAIN) new vascular care portfolio company established?
